# Feasibility Study of the Execution of an Efficacy Trial in the Nursing Home Setting

> **NCT00714519** · PHASE2 · WITHDRAWN · sponsor: **Healthpoint**

## Conditions studied

- Partial Thickness Wounds

## Interventions

- **DRUG:** Xenaderm® Ointment
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT00714519
- **Lead sponsor:** Healthpoint
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-07
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was terminated due to the inability to enroll subjects. No subjects were or ever will be enrolled into this study.
- **Last updated:** 2013-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00714519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00714519, "Feasibility Study of the Execution of an Efficacy Trial in the Nursing Home Setting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00714519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*